administration of naf , nacl , and mammalian calcitonin resulted in varying degree of hypolcalcaemia and hyperphosphataemia , whereas hypercalcaemia and hypophosphataemia developed during cacl2 treatment .
C0006668
calcitonin
C0020437
hypercalcaemia